282 related articles for article (PubMed ID: 30314805)
1. Neurofibromatosis type 2: Hearing preservation and rehabilitation.
Jia H; El Sayed MME; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
Neurochirurgie; 2018 Nov; 64(5):348-354. PubMed ID: 30314805
[TBL] [Abstract][Full Text] [Related]
2. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
[TBL] [Abstract][Full Text] [Related]
3. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
4. Natural history of vestibular schwannomas and hearing loss in NF2 patients.
Peyre M; Bernardeschi D; Sterkers O; Kalamarides M
Neurochirurgie; 2018 Nov; 64(5):342-347. PubMed ID: 26183546
[TBL] [Abstract][Full Text] [Related]
5. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
Samii M; Matthies C; Tatagiba M
Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
[TBL] [Abstract][Full Text] [Related]
6. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
8. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
[TBL] [Abstract][Full Text] [Related]
9. A new experience of auditory brainstem implantation in Malaysia.
Tang IP; Kevin Ng BH; Prepageran N; Donald Ngian SL; Albert Sii HW
Med J Malaysia; 2018 Oct; 73(5):347-348. PubMed ID: 30350824
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.
Kim JW; Han JH; Kim JW; Moon IS
Yonsei Med J; 2016 Nov; 57(6):1535-9. PubMed ID: 27593888
[TBL] [Abstract][Full Text] [Related]
11. Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
Massager N; Delbrouck C; Masudi J; De Smedt F; Devriendt D
B-ENT; 2013; 9(1):29-36. PubMed ID: 23641588
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
[TBL] [Abstract][Full Text] [Related]
15. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
16. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
18. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
[TBL] [Abstract][Full Text] [Related]
19. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
20. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
